BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 19152211)

  • 1. The role of binding kinetics in therapeutically useful drug action.
    Swinney DC
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):31-9. PubMed ID: 19152211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of drug-target residence time.
    Zhang R; Monsma F
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):488-96. PubMed ID: 19562645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding kinetics and mechanism of action: toward the discovery and development of better and best in class drugs.
    Zhang R; Monsma F
    Expert Opin Drug Discov; 2010 Nov; 5(11):1023-9. PubMed ID: 22827742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematical modeling of drug delivery.
    Siepmann J; Siepmann F
    Int J Pharm; 2008 Dec; 364(2):328-43. PubMed ID: 18822362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
    Gabrielsson J; Green AR
    J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elementary pharmacokinetics in clinical practice. 3: Practical pharmacokinetic applications.
    Paxton JW
    N Z Med J; 1981 Nov; 94(696):381-4. PubMed ID: 6948206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging applications of kinetic biomarkers in preclinical and clinical drug development.
    Turner SM; Hellerstein MK
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):115-26. PubMed ID: 15679179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand efficiency indices as guideposts for drug discovery.
    Abad-Zapatero C; Metz JT
    Drug Discov Today; 2005 Apr; 10(7):464-9. PubMed ID: 15809192
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of circadian rhythms on the kinetics of drugs in humans.
    Baraldo M
    Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):175-92. PubMed ID: 18248311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Principles of drug therapy. Pharmacokinetics].
    MMW Munch Med Wochenschr; 1979 Jul; 121(27):suppl 18-9. PubMed ID: 112440
    [No Abstract]   [Full Text] [Related]  

  • 11. Strategies at the interface of drug discovery and development: early optimization of the solid state phase and preclinical toxicology formulation for potential drug candidates.
    Palucki M; Higgins JD; Kwong E; Templeton AC
    J Med Chem; 2010 Aug; 53(16):5897-905. PubMed ID: 20527889
    [No Abstract]   [Full Text] [Related]  

  • 12. Target-drug interactions: first principles and their application to drug discovery.
    Núñez S; Venhorst J; Kruse CG
    Drug Discov Today; 2012 Jan; 17(1-2):10-22. PubMed ID: 21777691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of pharmaceutical profiling assays for optimization of drug-like properties.
    Di L; Kerns EH
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):495-504. PubMed ID: 16022186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic efficiency: the missing metric for enhancing compound quality?
    Holdgate GA; Gill AL
    Drug Discov Today; 2011 Nov; 16(21-22):910-3. PubMed ID: 21946261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics--questions of terminology and problems].
    von Hattingberg HM
    Arzneimittelforschung; 1975 Jul; 25(7a):1126-33. PubMed ID: 1242341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose equations without protein-binding parameters.
    Otozai K; Otaya H
    Int J Clin Pharmacol Biopharm; 1978 Oct; 16(10):463-6. PubMed ID: 700909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmaceutical aspects of drug side effects].
    Speiser P
    Ther Umsch; 1993 Jan; 50(1):37-41. PubMed ID: 8378865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expediting drug discovery: recent advances in fast medicinal chemistry--optimization of hits and leads.
    Edwards PJ; Allart B; Andrews MJ; Clase JA; Menet C
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):425-44. PubMed ID: 16889227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of pharmacologically active metabolites in drug discovery and development.
    Fura A
    Drug Discov Today; 2006 Feb; 11(3-4):133-42. PubMed ID: 16533711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanosuspensions in drug delivery.
    Rabinow BE
    Nat Rev Drug Discov; 2004 Sep; 3(9):785-96. PubMed ID: 15340388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.